GLIPITEC M1
TM Tablets are formulated to provide effective glycemic control through a combination of Glimepiride, a sulfonylurea that stimulates insulin secretion, and Metformin (sustained-release), which improves insulin sensitivity and reduces hepatic glucose production. This dual-action approach helps maintain stable blood glucose levels and is widely used in the management of type 2 diabetes mellitus.
Composition
- Glimepiride 1 mg
- Metformin Hydrochloride 500 mg (Sustained Release)
Key Features & Benefits
- Dual Mechanism Control: Enhances insulin release while improving insulin sensitivity
- Effective Glycemic Reduction: Helps maintain stable fasting and postprandial glucose levels
- Sustained-Release Advantage: Better gastrointestinal tolerability with prolonged action
- Proven Therapy Option: Widely prescribed combination in diabetes management
- Improved Compliance: Combination therapy reduces pill burden
Recommended Usage
- To be taken as prescribed by a healthcare professional
- Preferably taken with meals to minimize gastrointestinal discomfort
- Regular monitoring of blood glucose levels is advised
Safety Information
- Risk of hypoglycemia due to Glimepiride—monitor blood glucose regularly
- Use cautiously in elderly patients and those with renal or hepatic impairment
- Avoid skipping meals while on therapy
- Consult a doctor if symptoms such as dizziness, sweating, or weakness occur
Storage Instructions
- Store in a cool, dry place
- Protect from moisture and direct sunlight
- Keep out of reach of children
